Zhongheng Group (600252)
Guangxi Wuzhou Zhongheng Group Co., Ltd, together with its subsidiaries, researches, develops, manufactures, and sells pharmaceuticals in China. The company off...
- Open
- 2.30
- High
- 2.40
- Low
- 2.25
- Prev. Close
- 2.30
- Volume
- 1.23M
- Turnover
- 287.52M
- Avg Price
- 2.34
- Bid/Ask Ratio
- --
- Amplitude
- 6.52%
- 52wk High
- 3.10
- Volume Ratio
- 1.53
- Turnover Ratio
- 3.85%
Zhongheng Group Analyst Rating
View moreForecast & Rating
May 11, 2018Price forecast
--100.00%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Zhitong · Nov 3, 2025 at 05:52 AM
Sealand Securities: The concerted actors of the actual controller have completed the internal equity structure adjustment and share transfer
- Zhitong · Oct 30, 2025 at 05:57 AM
Zhongheng Group: Net profit loss of 2.4372 million yuan in the third quarter
- Zhitong · Aug 29, 2025 at 09:12 AM
Zhongheng Group: Net profit of 27.0776 million yuan in the first half of 2025, a year-on-year increase of 23.59%
- Zhitong · Aug 4, 2025 at 05:35 AM
Zhongheng Group: Wholly-owned subsidiary Zhongheng Innovation acquires a drug technology for treating chronic heart failure for 55 million yuan
- Zhitong · Jul 18, 2025 at 08:39 PM
Zhongheng Group: Has repurchased 99.5909 million shares, with a total amount of funds used of 249 million yuan
- Zhitong · May 30, 2025 at 04:59 AM
LaiMei Pharmaceutical: Guangtou Group plans to increase capital and expand shares in Guangtou JinKong with 25.94% of Zhongheng Group shares
